Table 3

Proinflammatory SNPs stratified by smoking status demonstrating the number of cases and controls, and Odds Ratio, 95%CI and p-values in an age-, race-adjusted additive model.

Gene
rs number
Smokers
Non-Smokers



Cases/Controls
OR*
95% CI
p-value
Cases/Controls
OR*
95% CI
p-value

CD14
rs2569190
77/31
2.05
1.09–3.87
0.027
82/121
0.93
0.62–1.39
0.72
IL1A
rs17561
106/48
1.68
0.84–3.32
0.14
111/156
1.05
0.69–1.60
0.83
IL1R1
rs3917318
102/45
1.138
0.67–1.94
0.64
108/155
1.07
0.74–1.54
0.72
IL1B
rs3917365
99/44
1.63
0.78–3.42
0.19
105/146
1.03
0.62–1.73
0.90
IL6
rs1800797
104/43
1.28
0.66–2.46
0.46
110/155
1.05
0.67–1.64
0.83

rs2069830
103/45
1.63
0.48–5.58
0.43
109/155
0.30
0.11–0.82
0.019

rs2069832
101/45
0.69
0.35–1.35
0.28
109/152
0.80
0.51–1.26
0.34
MMP3
rs679620
103/46
0.98
0.58–1.65
0.93
110/157
1.01
0.71–1.43
0.97

* Adjusted for age and race (African-American, Caucasian, and other).

Cole et al. Thrombosis Journal 2008 6:11   doi:10.1186/1477-9560-6-11